Actively Recruiting
Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
Led by Beijing Tiantan Hospital · Updated on 2025-01-17
206
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more suitable non-pharmacological therapy.
CONDITIONS
Official Title
Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 65 years
- Diagnosed with chronic migraine according to International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria
- No prior preventive migraine treatment or failed/intolerant to up to three prior prophylactic treatments including metoprolol/propranolol, amitriptyline, or flunarizine
You will not qualify if you...
- Body mass index (BMI) less than 15 kg/m2 or greater than 35 kg/m2
- Previous stellate ganglion block treatment
- History of other neurological disorders
- History of severe cardiopulmonary, liver, or kidney problems
- Allergic reaction to any study drugs
- Chronic opioid use
- Blood clotting problems with certain abnormal test results
- Infection or mass near injection site
- Neck structural changes from surgery or radiation
- Pregnant or breastfeeding
- Psychological disorders
- Refusal to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100050
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here